Boardroom Alpha
Boardroom Alpha
IBEX · Additional Proxy Materials (DEFA14A) · Filed December 1, 2025

Ibex Ltd — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
December 1, 2025
Ticker
IBEX
Accession
0001720420-25-000046
Boardroom Alpha · Filing insights

Ibex Limited's board approves a simple majority Bye-Laws amendment and will seek shareholder approval.

Proxy advisor rec.
About Ibex Ltd
Market cap
$427M
1Y TSR
+7.4%
3Y TSR
+12.8%
Board grade
A-
Sector
Technology
CEO
Robert Thomas Dechant
Last annual meeting: Dec 5, 2025 · View full Ibex Ltd profile →
Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
 
 
Filed by the Registrant        Filed by a Party other than the Registrant
Check the appropriate box:
 
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under §240.14a-12
IBEX Limited
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.





To the Shareholders of Ibex Limited:

This proxy statement supplement, dated December 1, 2025 (the “Supplement”), supplements the Definitive Proxy Statement on Schedule 14A of Ibex Limited (the “Company”), dated October 28, 2025, as supplemented on November 24, 2025, for the Company’s Annual Meeting of Shareholders to be held on December 5, 2025.

Board Commitment to Submit Management Proposal to Adopt a Majority Standard for Bye-Laws Amendments

In response to shareholder feedback, on November 26, 2025, the Board of Directors (the “Board”) of the Company approved an amendment to the Company’s Bye-Laws to adopt a simple majority vote standard for Bye-Laws amendments. This amendment is subject to approval by the Company’s shareholders under Bermuda law where the Company is incorporated. If approved by the shareholders, the simple majority vote standard will replace the current 75% approval threshold.

This commitment reflects the Board’s ongoing focus on strengthening corporate governance practices to align with leading market standards and shareholder priorities.

The Company commits to submit this Bye-Laws amendment for approval by its shareholders at the Company’s 2026 Annual General Meeting of Shareholders next year or earlier. While this vote may not occur for up to over a year, we are notifying our shareholders immediately, because this information may be relevant to shareholders in deciding on how to vote their shares at this year’s Annual General Meeting of Shareholders being held on December 5, 2025.

In particular, we note that Institutional Shareholder Services Inc. (“ISS”) previously recommended a vote against the re-election of our Governance Committee Chair because of the Board’s failure to remove, or subject to a sunset requirement, the supermajority vote requirement to amend our Bye-Laws. We believe the action taken by the Board to lower the 75% threshold for Bye-Laws amendments to a simple majority fully addresses ISS’ concerns.

The Board unanimously recommends a vote “FOR” each director nominee standing for election at this year’s Annual Meeting. If any shareholder previously submitted a proxy for the upcoming Annual Meeting and would like to change their vote, you may send in a new proxy which will automatically supersede the prior proxy. We urge you to vote “FOR” each of the Board nominees.

 
______________________________________________________________________________

Additional Information and Where to Find It

This communication relates to the upcoming annual meeting of the Company scheduled for December 5, 2025. In connection with this annual meeting, the Company has filed with the Securities and Exchange Commission (the “SEC”) a definitive proxy statement on Schedule 14A on October 28, 2025, as supplemented on November 24, 2025 (the “Proxy Statement”). This communication is not a substitute for the filed Proxy Statement or any other document that the Company may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT AND OTHER DOCUMENTS THAT HAVE BEEN OR MAY BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. Investors and security holders can obtain free copies of these documents and other documents filed with the SEC by the Company through the



website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by the Company will be available free of charge on the Company’s internet website at https://investors.ibex.co/shareholder-services/annual-meeting or upon written request to: Christy O’Connor, Assistant Secretary, IBEX Limited, 202 6th Street, Unit 401, Castle Rock, CO 80104.
Participants in Solicitation
The Company, its directors and certain of its executive officers may be considered participants in the solicitation of proxies in connection with the annual meeting. Information about the directors and executive officers of the Company is set forth in the Proxy Statement. To the extent that holdings of the Company’s securities by its directors or executive officers have changed since the amounts set forth in the Proxy Statement, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the Proxy Statement and other relevant materials to be filed with the SEC in respect of the annual meeting. These documents can be obtained free of charge from the sources indicated above.
Forward-Looking Statements
This document includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company’s plans to submit the Bye-Law amendment for approval by its shareholders at the Company’s 2026 Annual General Meeting is a forward-looking statement. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons. Risks and uncertainties that could cause our actual results to differ significantly from management’s expectations. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.



From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Ibex Ltd (IBEX)

Reference

Frequently asked questions

When did Ibex Ltd file this DEFA14A?
Ibex Ltd (IBEX) filed this Additional Proxy Materials (DEFA14A) with the SEC on December 1, 2025. The accession number assigned by EDGAR is 0001720420-25-000046.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Ibex Limited's board approves a simple majority Bye-Laws amendment and will seek shareholder approval. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Proxy advisor rec.". It appears above the filing body as a labeled pill.
Where can I find Ibex Ltd's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Ibex Ltd has filed under CIK 1720420, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer